诱导细胞焦亡的活性caspase-1作为抗癌DNA疫苗的遗传佐剂
本研究将组成性活性caspase-1变体与抗原表达DNA共免疫,体外证实其诱导pro-IL-1β成熟、IL-1β释放及gasdermin D依赖性细胞死亡;小鼠皮内接种含活性caspase-1质粒与卵清蛋白CD8 T细胞表位质粒的DNA疫苗后,活性caspase-1加速并放大抗原特异性CD8 T细胞应答;表达卵清蛋白的黑色素瘤细胞攻击后,佐剂组生存显著优于非佐剂组。
要点
- 体外转染组成性活性caspase-1 DNA诱导pro-IL-1β成熟、IL-1β释放及gasdermin D依赖性细胞死亡。
- 等摩尔剂量下与DNA疫苗同时给药,活性caspase-1加速并放大抗原特异性CD8 T细胞应答。
- 表达卵清蛋白的黑色素瘤细胞攻击后,活性caspase-1佐剂组生存显著优于非佐剂组。
核心结论
- 作者首次利用细胞焦亡通路开发了一种新型遗传佐剂,以提高抗癌DNA疫苗效果。
研究设计与样本
- 研究为动物实验,小鼠皮内接种由活性caspase-1质粒与编码卵清蛋白来源CD8 T细胞表位的质粒组成的DNA疫苗。
主要发现
- 体外转染组成性活性caspase-1 DNA诱导pro-IL-1β成熟、IL-1β释放及gasdermin D依赖性细胞死亡。
- 活性caspase-1与DNA疫苗以等摩尔剂量同时给药时,加速并放大抗原特异性CD8 T细胞应答。
- 表达卵清蛋白的黑色素瘤细胞攻击后,活性caspase-1佐剂疫苗组生存显著优于非佐剂组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pyroptosis is a recently discovered form of inflammatory programmed necrosis characterized by caspase-1-mediated and gasdermin D-dependent cell death leading to the release of pro-inflammatory cytokines such as Interleukin-1 beta (IL-1β). Here, we evaluated whether pyroptosis could be exploited in DNA vaccination by incorporating a constitutively active variant of caspase-1 to the antigen-expressing DNA. In vitro, transfection with constitutively active caspase-1 DNA induced pro-IL-1β maturation and IL-1β release as well as gasdermin D-dependent cell death. To test active caspase-1 as a genetic adjuvant for the induction of antigen-specific T cell responses, mice were vaccinated intradermally with a DNA vaccine consisting of the active caspase-1 plasmid together with a plasmid encoding an ovalbumin-derived CD8 T cell epitope. Active caspase-1 accelerated and amplified antigen-specific CD8 T cell responses when administered simultaneously with the DNA vaccine at an equimolar dose. Moreover, upon challenge with melanoma cells expressing ovalbumin, mice vaccinated with the antigen vaccine adjuvanted with active caspase-1 showed significantly better survival compared to the non-adjuvanted group. In conclusion, we have developed a novel genetic adjuvant that for the first time employs the pyroptosis pathway to improve DNA vaccination against cancer.
引用
- Arakelian T, Oosterhuis K, Tondini E, et al. Pyroptosis-inducing active caspase-1 as a genetic adjuvant in anti-cancer DNA vaccination. Vaccine. 2022. PMID: 35177300. doi:10.1016/j.vaccine.2022.02.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。